| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
59 | 59 | 441 | 1,924 | 18,051 |
| Cost of Revenue
|
0 | 0 | 366 | -1,284 | -3,434 |
|
Gross Profit
|
59 | 59 | 807 | 640 | 14,617 |
| Selling, General and Administrative Expenses
|
-29,838 | -22,900 | -17,241 | -10,300 | -20,711 |
|
Research and Development Expenses
|
-65,779 | -50,084 | -24,437 | -13,784 | -31,308 |
| Depreciation, Amortization and Depletion
|
-- | -- | -- | 0 | -38 |
|
Operating Income/Expenses
|
-95,617 | -72,984 | -41,678 | -24,084 | -52,057 |
|
Total Operating Profit/Loss
|
-95,558 | -72,925 | -40,871 | -23,444 | -37,440 |
| Total Net Finance Income/Expense
|
8,805 | 4,351 | 3,312 | -3,417 | -4,170 |
| Net Investment Income
|
4,840 | -9,520 | 39,405 | -720 | 0 |
| Irregular Income/Expenses
|
-6,574 | 0 | -36,861 | -3,907 | 0 |
|
Other Income/Expense, Non-Operating
|
-8 | -- | -5 | -42 | -20 |
|
Non-Operating Income/Expenses, Total
|
7,071 | -5,169 | 5,856 | -8,086 | -4,190 |
|
Pretax Income
|
-88,487 | -78,094 | -35,015 | -31,530 | -41,630 |
|
Provision for Income Tax
|
-166 | -165 | -114 | -14 | -28 |
|
Net Income from Continuing Operations
|
-88,653 | -78,259 | -35,129 | -31,544 | -41,658 |
|
Discontinued Operations
|
-- | -- | -- | -- | 0 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-88,653 | -78,259 | -35,129 | -31,544 | -41,658 |
|
Net Income after Non-Controlling/Minority Interests
|
-88,653 | -78,259 | -35,129 | -31,544 | -41,658 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
-17,575 | -- | -- | -- | -- |
|
Net Income Available to Common Stockholders
|
-88,653 | -78,259 | -35,129 | -31,544 | -41,658 |
|
Dilution to Earnings
|
-36,025 | -- | -- | -- | -- |
|
Diluted Net Income Available to Common Stockholders
|
-88,653 | -78,259 | -35,129 | -31,544 | -41,658 |
| Basic EPS
|
-2.26 | -5.84 | -7.94 | -113.58 | -1.06k |
| Diluted EPS
|
-2.26 | -5.84 | -20.91 | -113.58 | -1.06k |
|
Basic Weighted Average Shares Outstanding
|
34,346.34 | 13,404.83 | 4,426.15 | 277.73 | 39.20 |
|
Diluted Weighted Average Shares Outstanding
|
34,346.34 | 13,404.83 | 7,496.39 | 277.73 | 39.20 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-97,292 | -82,445 | -38,327 | -28,113 | -37,460 |
|
EBITDA
|
-97,224 | -82,101 | -38,158 | -27,955 | -37,294 |
12/31/2022 - 10/14/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade